Multimodal AI Services to Accelerate Precision Medicine for Type 1 Diabetes

The National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases seek multimodal artificial intelligence services to accelerate precision medicine for type 1 diabetes. The buyer requires vendors to integrate existing complementary, longitudinal, and multimodal human pancreas and clinical datasets to study type 1 diabetes across biological levels, tissues, and disease stages. This milestone-driven research project aims to answer fundamental questions about type 1 diabetes biology and advance personalized medicine strategies. Eligibility restricts participation strictly to onshore United States organizations. Vendors will perform all requested work offsite. Interested bidders must submit their responses digitally through email or online portal options. The buyer invites vendors to submit proposals to establish the project budget. The provided source materials omit specific evaluation criteria, explicit submission deadlines, and exact budget caps for this funding opportunity.